Personalized therapy in oncology, considering pharmacogenetics and current antineoplastics

Authors

DOI:

https://doi.org/10.33448/rsd-v9i7.4312

Keywords:

Oncology; Pharmacogenetics; Antineoplastics; Drugstore.

Abstract

Humans can express very different therapeutic responses when the same drug is administered. However, the variations may be due to the phenotype, since differences in age, weight, gender, health and diet are among the important factors, but the genotype also contributes to the environment. However, the implementation of pharmacogenetic tests in clinical practice has been slow. There are still many barriers present that lead to its underutilization. The objective of present study is to present a systematic review of meta-analysis on personalized therapy in oncology, considering pharmacogenetics and current antineoplastic agents and as specific objectives: to discuss the development of pharmacogenomics in relation to antineoplastic agents. According to the search strategies, a total of 168 articles were found in the databases selected for the search, with 32 articles in the Pubmed database, 24 in the Lilacs database and 12 in the Scielo database. We conclude that the relationship to the pharmacokinetics and dynamics of drugs used in the treatment of different diseases, may be available in a large database. The benefits of pharmacogenetics range from choosing the drug that has the best therapeutic effects to increasing the effectiveness of clinical trials in discovering new drugs.

References

Azeved, MO, Felipe MSS, Brígido MM, Maranhão AQ & Souza MT.(2015). Técnicas básicas em biologia molecular. Brasília: UnB.

Borém A, Giudice M & Sediyama T.(2017). Melhoramento genômico. Viçosa: Universidade Federal de Viçosa. 224 p.

Evans WE & Relling MV. (2019). Pharmacogenomics: translating functional genomics into rational therapeutics. Science, Washington, 286(5439): 487- 91.

Felipe ES. (2016). Farmacogenômica: Aspectos éticos. Gazeta médica da Bahia, Salvador. 74(2): 145-48.

Farraye FA, Odze RD, Eaden J, Itzkowitz SH. (2018). AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenter‐ ology. 138:746–74.

Thorn RV. (2017). Farmacogenética e Implicações Terapêuticas no Câncer. Revista Brasileira de Cancerologia.

Valle A et al. (2009). VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty. Clinical Orthopaedics and Related Research. Julho. 467: 1773-80.

Published

30/05/2020

How to Cite

SILVA, H. R.; DA SILVA, B. B. L.; SILVA, T. A. da; ALVES, A. K. R.; ALVES, A. K. R.; NASCIMENTO, C. L. da C.; PEREIRA, N. M.; REIS, M. D. C.; ROCHA, Álvaro S. C.; BORGES, M. J.; SILVA, K. S. S. da; OLIVEIRA, A. C. L.; SOUSA, L. K. R. de; PINHEIRO NETO, J. C.; PESSOA, G. T. Personalized therapy in oncology, considering pharmacogenetics and current antineoplastics. Research, Society and Development, [S. l.], v. 9, n. 7, p. e631974312, 2020. DOI: 10.33448/rsd-v9i7.4312. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/4312. Acesso em: 16 nov. 2024.

Issue

Section

Review Article